-
In Hawaii, Rat Lungworm Disease Infects People but Eludes Researchers Opens in a new window)
A brain-invading parasite has made nearly 100 people sick in Hawaii in the last decade. How worried should health officials be?
-
Cancer Campaign Coverage Puts Heat on Pharmac Opens in a new window)
The New Zealand government’s drug-buying agency has been getting a lot of media coverage lately.
-
More Transparency on Costs for Patients Needed Opens in a new window)
Transparency needs to be improved by increasing publicly available information on out-of-pocket costs together with health outcomes.
-
Pharmac: The NZ Buyer’s Club Opens in a new window)
Unlike other developed countries, New Zealand puts a ceiling on its medicines budget, and drug buying agency Pharmac is very disciplined: In 26 years of existence, it has never breached its spending cap.
-
The Numbers Don’t Lie: How Inequality is Baked into the NZ Health System Opens in a new window)
It turns out healthcare isn’t maths.
-
Who is Paying the Price of Whole-Genome Sequencing in Cancer Care? Opens in a new window)
Whole-genome sequencing is changing the cancer treatment landscape, but we have to understand its use in the real-world to support a more sustainable, affordable health system.
-
Drug Company Boss Calls for Inquiry Over Breast Cancer Drug Prices Opens in a new window)
'Pharmac' said it's aware firms can charge up to 65 percent more for medicines like Ibrance and Kadcyla in New Zealand than in countries like Malaysia.
-
How Much Does it Cost to Have Cancer? Opens in a new window)
Out-of-pocket costs are brutal sucker punches for cancer patients. Where do the costs come from? How steep are they? And how are the Coalition and Labor aiming to help reduce "bill shock"?
-
Australia Seeks Cancer Care Plan Opens in a new window)
Shorten promises $2.3 billion package to relieve costs for cancer patients.
-
Pfizer and Roche Answer Questions About Access to Breast Cancer Drugs Ibrance and Kadcyla Opens in a new window)
The breast cancer drug Ibrance, also known as Palbociclib, is available to women in Malaysia at around $2000 per month. In New Zealand, where it is not funded, it costs around $6000 per month.
-
Thalidomide Survivors Seek Justice in 'World’s Worst Pharmaceutical Disaster'
Two pills. That’s all it took to change Lisa McManus’s life. She was left physically disfigured and emotionally scarred by one of the world's worst pharmaceutical disasters.
-
Treat Medicines Like Netflix Treats Shows Opens in a new window)
In 2015, Australia signed agreements with producers of the new hep C cures. For 1 billion Australian dollars — $766 million U.S. — Australia gets, for five years, all the hep C medicine it can use.
-
The Australian Government to Subsidize Cost of New Multiple Sclerosis Drug Opens in a new window)
Multiple sclerosis patients to save $54,000 a year after Mavenclad medication listed on PBS.
-
Papua New Guinea Is Rich in Resources but Poor in Health Opens in a new window)
Polio was vanquished by the Pacific nation of Papua New Guinea 18 years ago.
-
Who Knows the True Cost of Medicines? Opens in a new window)
Confidential deals which see New Zealand receive hundreds of millions of dollars in rebates from pharmaceutical companies unfairly hide the real cost of drugs.
